α4 nicotinic receptors on GABAergic neurons mediate a cholinergic analgesic circuit in the substantia nigra pars reticulata.
cholinergic system
chronic nicotine
nicotinic acetylcholine receptor
pain
pedunculopontine nucleus
substantia nigra pars reticulata
Journal
Acta pharmacologica Sinica
ISSN: 1745-7254
Titre abrégé: Acta Pharmacol Sin
Pays: United States
ID NLM: 100956087
Informations de publication
Date de publication:
04 Mar 2024
04 Mar 2024
Historique:
received:
20
09
2023
accepted:
25
01
2024
medline:
5
3
2024
pubmed:
5
3
2024
entrez:
4
3
2024
Statut:
aheadofprint
Résumé
Nicotinic acetylcholine receptors (nAChRs) regulate pain pathways with various outcomes depending on receptor subtypes, neuron types, and locations. But it remains unknown whether α4β2 nAChRs abundantly expressed in the substantia nigra pars reticulata (SNr) have potential to mitigate hyperalgesia in pain states. We observed that injection of nAChR antagonists into the SNr reduced pain thresholds in naïve mice, whereas injection of nAChR agonists into the SNr relieved hyperalgesia in mice, subjected to capsaicin injection into the lower hind leg, spinal nerve injury, chronic constriction injury, or chronic nicotine exposure. The analgesic effects of nAChR agonists were mimicked by optogenetic stimulation of cholinergic inputs from the pedunculopontine nucleus (PPN) to the SNr, but attenuated upon downregulation of α4 nAChRs on SNr GABAergic neurons and injection of dihydro-β-erythroidine into the SNr. Chronic nicotine-induced hyperalgesia depended on α4 nAChRs in SNr GABAergic neurons and was associated with the reduction of ACh release in the SNr. Either activation of α4 nAChRs in the SNr or optogenetic stimulation of the PPN-SNr cholinergic projection mitigated chronic nicotine-induced hyperalgesia. Interestingly, mechanical stimulation-induced ACh release was significantly attenuated in mice subjected to either capsaicin injection into the lower hind leg or SNI. These results suggest that α4 nAChRs on GABAergic neurons mediate a cholinergic analgesic circuit in the SNr, and these receptors may be effective therapeutic targets to relieve hyperalgesia in acute and chronic pain, and chronic nicotine exposure.
Identifiants
pubmed: 38438581
doi: 10.1038/s41401-024-01234-7
pii: 10.1038/s41401-024-01234-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.
Références
Busse JW, Wang L, Kamaleldin M, Craigie S, Riva JJ, Montoya L, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA. 2018;320:2448–60.
doi: 10.1001/jama.2018.18472
Hylands-White N, Duarte RV, Raphael JH. An overview of treatment approaches for chronic pain management. Rheumatol Int. 2017;37:29–42.
doi: 10.1007/s00296-016-3481-8
Noori A, Sadeghirad B, Wang L, Siemieniuk RAC, Shokoohi M, Kum E, et al. Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised trials. Br J Anaesth. 2022;129:394–406.
doi: 10.1016/j.bja.2022.05.031
Higgins C, Smith BH, Matthews K. Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. Br J Anaesth. 2019;122:e114–e26.
doi: 10.1016/j.bja.2018.09.019
Koller G, Schwarzer A, Halfter K, Soyka M. Pain management in opioid maintenance treatment. Expert Opin Pharmacother. 2019;20:1993–2005.
doi: 10.1080/14656566.2019.1652270
Noori SA, Aiyer R, Yu J, White RS, Mehta N, Gulati A. Nonopioid versus opioid agents for chronic neuropathic pain, rheumatoid arthritis pain, cancer pain and low back pain. Pain Manag. 2019;9:205–16.
doi: 10.2217/pmt-2018-0052
Dulawa SC, Janowsky DS. Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics. Mol Psychiatry. 2019;24:694–709.
doi: 10.1038/s41380-018-0219-x
Naser PV, Kuner R. Molecular, cellular and circuit basis of cholinergic modulation of pain. Neuroscience. 2018;387:135–48.
doi: 10.1016/j.neuroscience.2017.08.049
Schechtmann G, Song Z, Ultenius C, Meyerson BA, Linderoth B. Cholinergic mechanisms involved in the pain relieving effect of spinal cord stimulation in a model of neuropathy. Pain. 2008;139:136–45.
doi: 10.1016/j.pain.2008.03.023
Umana IC, Daniele CA, McGehee DS. Neuronal nicotinic receptors as analgesic targets: it’s a winding road. Biochem Pharmacol. 2013;86:1208–14.
doi: 10.1016/j.bcp.2013.08.001
Umana IC, Daniele CA, Miller BA, Abburi C, Gallagher K, Brown MA, et al. Nicotinic modulation of descending pain control circuitry. Pain. 2017;158:1938–50.
doi: 10.1097/j.pain.0000000000000993
Ji YW, Shen ZL, Zhang X, Zhang K, Jia T, Xu X, et al. Plasticity in ventral pallidal cholinergic neuron-derived circuits contributes to comorbid chronic pain-like and depression-like behaviour in male mice. Nat Commun. 2023;14:2182.
doi: 10.1038/s41467-023-37968-x
Marks MJ, Grady SR, Salminen O, Paley MA, Wageman CR, McIntosh JM, et al. α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration. J Neurochem. 2014;130:185–98.
doi: 10.1111/jnc.12721
Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, et al. Nicotine activation of α4* receptors: sufficient for reward, tolerance, and sensitization. Science. 2004;306:1029–32.
doi: 10.1126/science.1099420
Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci. 2003;23:3176–85.
doi: 10.1523/JNEUROSCI.23-08-03176.2003
Wu J. Understanding of nicotinic acetylcholine receptors. Acta Pharmacol Sin. 2009;30:653–5.
doi: 10.1038/aps.2009.89
Xiao C, Zhou CY, Jiang JH, Yin C. Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence. Acta Pharmacol Sin. 2020;41:1–9.
doi: 10.1038/s41401-019-0299-4
Nashmi R, Xiao C, Deshpande P, McKinney S, Grady SR, Whiteaker P, et al. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 2007;27:8202–18.
doi: 10.1523/JNEUROSCI.2199-07.2007
Buisson B, Bertrand D. Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J Neurosci. 2001;21:1819–29.
doi: 10.1523/JNEUROSCI.21-06-01819.2001
McGranahan TM, Patzlaff NE, Grady SR, Heinemann SF, Booker TK. α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. J Neurosci. 2011;31:10891–902.
doi: 10.1523/JNEUROSCI.0937-11.2011
Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, et al. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature. 1998;391:173–7.
doi: 10.1038/34413
Xiao C, Nashmi R, McKinney S, Cai H, McIntosh JM, Lester HA. Chronic nicotine selectively enhances α4β2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J Neurosci. 2009;29:12428–39.
doi: 10.1523/JNEUROSCI.2939-09.2009
Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Lena C, et al. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci. 2003;23:7820–9.
doi: 10.1523/JNEUROSCI.23-21-07820.2003
Klink R, de Kerchove d’Exaerde A, Zoli M, Changeux JP. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci. 2001;21:1452–63.
doi: 10.1523/JNEUROSCI.21-05-01452.2001
Estakhr J, Abazari D, Frisby K, McIntosh JM, Nashmi R. Differential control of dopaminergic excitability and locomotion by cholinergic inputs in mouse substantia nigra. Curr Biol. 2017;27:1900–14.e4.
doi: 10.1016/j.cub.2017.05.084
Metaxas A, Bailey A, Barbano MF, Galeote L, Maldonado R, Kitchen I. Differential region-specific regulation of α4β2* nAChRs by self-administered and non-contingent nicotine in C57BL/6J mice. Addict Biol. 2010;15:464–79.
doi: 10.1111/j.1369-1600.2010.00246.x
Miwa JM, Freedman R, Lester HA. Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron. 2011;70:20–33.
doi: 10.1016/j.neuron.2011.03.014
Yin C, Jia T, Luan Y, Zhang X, Xiao C, Zhou C. A nigra-subthalamic circuit is involved in acute and chronic pain states. Pain. 2022;163:1952–66.
doi: 10.1097/j.pain.0000000000002588
Jia T, Wang YD, Chen J, Zhang X, Cao JL, Xiao C, et al. A nigro-subthalamo-parabrachial pathway modulates pain-like behaviors. Nat Commun. 2022;13:7756.
doi: 10.1038/s41467-022-35474-0
WHO report on the global tobacco epidemic 2021: addressing new and emerging products. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
Wipfli H, Samet JM. One hundred years in the making: the global tobacco epidemic. Annu Rev Public Health. 2016;37:149–66.
doi: 10.1146/annurev-publhealth-032315-021850
De Biasi M, Dani JA. Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci. 2011;34:105–30.
doi: 10.1146/annurev-neuro-061010-113734
Wu J. Double target concept for smoking cessation. Acta Pharmacol Sin. 2010;31:1015–8.
doi: 10.1038/aps.2010.137
Anderson KL, Pinkerton KE, Uyeminami D, Simons CT, Carstens MI, Carstens E. Antinociception induced by chronic exposure of rats to cigarette smoke. Neurosci Lett. 2004;366:86–91.
doi: 10.1016/j.neulet.2004.05.020
Shi Y, Weingarten TN, Mantilla CB, Hooten WM, Warner DO. Smoking and pain: pathophysiology and clinical implications. Anesthesiology. 2010;113:977–92.
doi: 10.1097/ALN.0b013e3181ebdaf9
Alfonso-Rodriguez J, Wang S, Zeng X, Candiotti KA, Zhang Y. Mechanism of electroacupuncture analgesia on nicotine withdrawal-induced hyperalgesia in a rat model. Evid Based Complement Altern Med. 2022;2022:7975803.
doi: 10.1155/2022/7975803
Luan Y, Tang D, Wu H, Gu W, Wu Y, Cao JL, et al. Reversal of hyperactive subthalamic circuits differentially mitigates pain hypersensitivity phenotypes in parkinsonian mice. Proc Natl Acad Sci USA. 2020;117:10045–54.
doi: 10.1073/pnas.1916263117
Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd, Editor. (Academic Press, San Diego, 2001).
Wang D, Liu P, Mao X, Zhou Z, Cao T, Xu J, et al. Task-demand-dependent neural representation of odor information in the olfactory bulb and posterior piriform cortex. J Neurosci. 2019;39:10002–18.
doi: 10.1523/JNEUROSCI.1234-19.2019
Wu H, Yan X, Tang D, Gu W, Luan Y, Cai H, et al. Internal states influence the representation and modulation of food intake by subthalamic neurons. Neurosci Bull. 2020;36:1355–68.
doi: 10.1007/s12264-020-00533-3
Huang YK, Lu YG, Zhao X, Zhang JB, Zhang FM, Chen Y, et al. Cytokine activin C ameliorates chronic neuropathic pain in peripheral nerve injury rodents by modulating the TRPV1 channel. Br J Pharmacol. 2020;177:5642–57.
doi: 10.1111/bph.15284
Zhou C, Luo ZD. Nerve injury-induced calcium channel α2δ1 protein dysregulation leads to increased pre-synaptic excitatory input into deep dorsal horn neurons and neuropathic allodynia. Eur J Pain. 2015;19:1267–76.
doi: 10.1002/ejp.656
Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol. 1980;20:441–62.
doi: 10.1146/annurev.pa.20.040180.002301
Treede RD, Meyer RA, Raja SN, Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol. 1992;38:397–421.
doi: 10.1016/0301-0082(92)90027-C
Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 2000;87:149–58.
doi: 10.1016/S0304-3959(00)00276-1
Zhang H, Qian YL, Li C, Liu D, Wang L, Wang XY, et al. Brain-derived neurotrophic factor in the mesolimbic reward circuitry mediates nociception in chronic neuropathic pain. Biol Psychiatry. 2017;82:608–18.
doi: 10.1016/j.biopsych.2017.02.1180
Wang HR, Hu SW, Zhang S, Song Y, Wang XY, Wang L, et al. KCNQ channels in the mesolimbic reward circuit regulate nociception in chronic pain in mice. Neurosci Bull. 2021;37:597–610.
doi: 10.1007/s12264-021-00668-x
Zhou C, Gu W, Wu H, Yan X, Deshpande P, Xiao C, et al. Bidirectional dopamine modulation of excitatory and inhibitory synaptic inputs to subthalamic neuron subsets containing α4β2 or α7 nAChRs. Neuropharmacology. 2019;148:220–8.
doi: 10.1016/j.neuropharm.2019.01.015
Fan JP, Geng HZ, Ji YW, Jia T, Treweek JB, Li AA, et al. Age-dependent alterations in key components of the nigrostriatal dopaminergic system and distinct motor phenotypes. Acta Pharmacol Sin. 2022;43:862–75.
doi: 10.1038/s41401-021-00713-5
Xiao C, Cho JR, Zhou C, Treweek JB, Chan K, McKinney SL, et al. Cholinergic mesopontine signals govern locomotion and reward through dissociable midbrain pathways. Neuron. 2016;90:333–47.
doi: 10.1016/j.neuron.2016.03.028
Grace AA, Onn SP. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J Neurosci. 1989;9:3463–81.
doi: 10.1523/JNEUROSCI.09-10-03463.1989
Lacey MG, Mercuri NB, North RA. Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J Neurosci. 1989;9:1233–41.
doi: 10.1523/JNEUROSCI.09-04-01233.1989
Benarroch EE. Pedunculopontine nucleus: functional organization and clinical implications. Neurology. 2013;80:1148–55.
doi: 10.1212/WNL.0b013e3182886a76
Mena-Segovia J, Bolam JP. Rethinking the pedunculopontine nucleus: from cellular organization to function. Neuron. 2017;94:7–18.
doi: 10.1016/j.neuron.2017.02.027
Xiao C, Miwa JM, Henderson BJ, Wang Y, Deshpande P, McKinney SL, et al. Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus. J Neurosci. 2015;35:3734–46.
doi: 10.1523/JNEUROSCI.3528-14.2015
Jing M, Li Y, Zeng J, Huang P, Skirzewski M, Kljakic O, et al. An optimized acetylcholine sensor for monitoring in vivo cholinergic activity. Nat Methods. 2020;17:1139–46.
doi: 10.1038/s41592-020-0953-2
Jing M, Zhang P, Wang G, Feng J, Mesik L, Zeng J, et al. A genetically encoded fluorescent acetylcholine indicator for in vitro and in vivo studies. Nat Biotechnol. 2018;36:726–37.
doi: 10.1038/nbt.4184
Carstens E, Carstens MI. Sensory effects of nicotine and tobacco. Nicotine Tob Res. 2022;24:306–15.
doi: 10.1093/ntr/ntab086
Liu D, Tang QQ, Wang D, Song SP, Yang XN, Hu SW, et al. Mesocortical BDNF signaling mediates antidepressive-like effects of lithium. Neuropsychopharmacology. 2020;45:1557–66.
doi: 10.1038/s41386-020-0713-0
Liu D, Tang QQ, Yin C, Song Y, Liu Y, Yang JX, et al. Brain-derived neurotrophic factor-mediated projection-specific regulation of depressive-like and nociceptive behaviors in the mesolimbic reward circuitry. Pain. 2018;159:175.
doi: 10.1097/j.pain.0000000000001083
Lester HA, Xiao C, Srinivasan R, Son CD, Miwa J, Pantoja R, et al. Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J. 2009;11:167–77.
doi: 10.1208/s12248-009-9090-7
Nashmi R, Lester H. Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation. Biochem Pharmacol. 2007;74:1145–54.
doi: 10.1016/j.bcp.2007.06.040